Literature DB >> 8344342

Cytokine production and heterogeneity of primary stromal cells that support B lymphopoiesis.

P L Witte1, L M Frantsve, M Hergott, S M Rahbe.   

Abstract

Many reports document that bone marrow stromal cells or their cytokine products can influence the formation of B cells in vitro. Most of this data comes from studies using lines or clones of stromal cells after multiple passage in culture, which could alter gene expression. Our aim in the present study was to determine which cytokines are produced by normal stromal cells under conditions that promote B lymphopoiesis. Primary cultured stromal cells were isolated on FACS from active Whitlock cultures. These cells proved to be relatively homogeneous in expression of cell surface antigens (CD44, VCAM-1, MECA10, and a molecule marked by hamster anti-mouse 8.28 monoclonal antibody). RNA from unselected Whitlock cultured adherent cells and sorted stromal cells from the same cultures were subjected to reverse transcriptase polymerase chain reaction to assess constitutive expression of several cytokine genes. Transcripts for interleukin-1 beta (IL-1 beta), IL-7, macrophage (M)-colony-stimulating factor (CSF), stem cell growth factor (SCGF), insulin-like growth factor 1 (IGF-1) and occasionally leukemia inhibitory factor were detected in RNA from intact cultures. Messages for IL-7, M-CSF, and SCGF were selectively contained within the isolated stromal cell fraction; whereas, IL-1 beta was found solely within the non-stromal cell fraction. IGF-1 was transcribed by both stromal cells and macrophages in Whitlock cultures. No evidence was found for constitutive expression of IL-1 alpha, IL-4, IL-6, or granulocyte-macrophage-CSF. This is in contrast to some reported stromal cell lines and clones. To determine if all primary stromal cells from active lymphopoietic cultures produced IL-7, the isolated cells were stained to reveal cytoplasmic IL-7 protein. A majority of the cells produced IL-7, but about 20% had no detectable IL-7 protein. Taken together, our results suggest that the primary stromal cells are a distinguishable cell type but functional subsets may exist. In regard to the differences in IL-7 production, the primary cell phenotype appears to mirror at least one division noted among the stromal cell lines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344342     DOI: 10.1002/eji.1830230812

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Systemic administration of TLR3 agonist induces IL-7 expression and IL-7-dependent CXCR3 ligand production in the lung.

Authors:  Jun-O Jin; Qing Yu
Journal:  J Leukoc Biol       Date:  2012-12-27       Impact factor: 4.962

2.  Apoptosis and interleukin 7 gene expression in chronic B-lymphocytic leukemia cells.

Authors:  B W Long; P L Witte; G N Abraham; S A Gregory; J M Plate
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

3.  NK cells in the CD19- B220+ bone marrow fraction are increased in senescence and reduce E2A and surrogate light chain proteins in B cell precursors.

Authors:  Anne M King; Patricia Keating; Anjali Prabhu; Bonnie B Blomberg; Richard L Riley
Journal:  Mech Ageing Dev       Date:  2009-03-24       Impact factor: 5.432

Review 4.  Antigen and cytokine receptor signals guide the development of the naïve mature B cell repertoire.

Authors:  Sarah L Rowland; Kathryn Tuttle; Raul M Torres; Roberta Pelanda
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

5.  Visualization and identification of IL-7 producing cells in reporter mice.

Authors:  Renata I Mazzucchelli; Søren Warming; Scott M Lawrence; Masaru Ishii; Mehrnoosh Abshari; A Valance Washington; Lionel Feigenbaum; Andrew C Warner; Davis J Sims; Wen Qing Li; Julie A Hixon; Daniel H D Gray; Benjamin E Rich; Matthew Morrow; Miriam R Anver; James Cherry; Dieter Naf; Lawrence R Sternberg; Daniel W McVicar; Andrew G Farr; Ronald N Germain; Keith Rogers; Nancy A Jenkins; Neal G Copeland; Scott K Durum
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.